Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016 (2016), Article ID 9362169, 11 pages
http://dx.doi.org/10.1155/2016/9362169
Research Article

Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome

1Department of Perinatology and Obstetrics, Medical University of Bialystok, Marii Sklodowskiej-Curie 24a, 15-276 Bialystok, Poland
2Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Marii Sklodowskiej-Curie 24a, 15-276 Bialystok, Poland
3Faculty of Computer Science, Bialystok University of Technology, Wiejska 45A, 15-351 Bialystok, Poland

Received 21 July 2015; Revised 14 January 2016; Accepted 27 January 2016

Academic Editor: Mario Clerici

Copyright © 2016 Karol Charkiewicz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. L. Sherman, E. G. Allen, L. H. Bean, and S. B. Freeman, “Epidemiology of Down syndrome,” Mental Retardation and Developmental Disabilities Research Reviews, vol. 13, no. 3, pp. 221–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Ghosh, E. Feingold, and S. K. Dey, “Etiology of down syndrome: evidence for consistent association among altered meiotic recombination, nondisjunction, and maternal age across populations,” American Journal of Medical Genetics A, vol. 149, no. 7, pp. 1415–1420, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. Benn, J. Ying, T. Beazoglou, and J. F. X. Egan, “Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results,” Prenatal Diagnosis, vol. 21, no. 1, pp. 46–51, 2001. View at Google Scholar · View at Scopus
  4. R. W. K. Chiu, R. Akolekar, Y. W. L. Zheng et al., “Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study,” British Medical Journal, vol. 342, article c7401, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ehrich, C. Deciu, T. Zwiefelhofer et al., “Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting,” American Journal of Obstetrics and Gynecology, vol. 204, no. 3, pp. 205.e1–205.e11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. B. Sparks, E. T. Wang, C. A. Struble et al., “Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy,” Prenatal Diagnosis, vol. 32, no. 1, pp. 3–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. G. E. Palomaki, E. M. Kloza, G. M. Lambert-Messerlian et al., “DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study,” Genetics in Medicine, vol. 13, no. 11, pp. 913–920, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Vesce, C. Scapoli, G. Giovannini et al., “Cytokine imbalance in pregnancies with fetal chromosomal abnormalities,” Human Reproduction, vol. 17, no. 3, pp. 803–808, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Costa, L. Sommese, A. Casamassimi et al., “Impairment of circulating endothelial progenitors in Down syndrome,” BMC Medical Genomics, vol. 3, article 40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. R. O. Bahado-Singh, R. Akolekar, R. Mandal et al., “Metabolomic analysis for first-trimester Down syndrome prediction,” American Journal of Obstetrics and Gynecology, vol. 208, no. 5, pp. 371.e1–371.e8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Laudanski, A. Lemancewicz, P. Pierzynski, M. Akerlund, and T. Laudanski, “Decreased serum level of macrophage inflammatory chemokine-3β/CCL19 in preterm labor and delivery,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 124, no. 1, pp. 23–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Kuzmicki, B. Telejko, A. Zonenberg et al., “Circulating pro- and anti-inflammatory cytokines in Polish women with gestational diabetes,” Hormone and Metabolic Research, vol. 40, no. 8, pp. 556–560, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Laudanski, M. Zbucka-Kretowska, K. Charkiewicz, S. Wolczynski, D. Wojcik, and R. Charkiewicz, “Maternal plasma and amniotic fluid chemokines screening in fetal down syndrome,” Mediators of Inflammation, vol. 2014, Article ID 835837, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Charkiewicz, A. Blachnio-Zabielska, M. Zbucka-Kretowska, S. Wolczynski, and P. Laudanski, “Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndrome,” PLoS ONE, vol. 10, no. 5, Article ID e0127732, 2015. View at Publisher · View at Google Scholar
  15. G. K. Smyth, “Limma: linear models for microarray data,” in Bioinformatics and Computational Biology Solutions Using R and Bioconductor, Statistics for Biology and Health, pp. 397–420, Springer, New York, NY, USA, 2005. View at Publisher · View at Google Scholar
  16. J. D. Silver, M. E. Ritchie, and G. K. Smyth, “Microarray background correction: maximum likelihood estimation for the normal-exponential convolution,” Biostatistics, vol. 10, no. 2, pp. 352–363, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. G. K. Smyth and T. Speed, “Normalization of cDNA microarray data,” Methods, vol. 31, no. 4, pp. 265–273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. G. K. Smyth, “Linear models and empirical bayes methods for assessing differential expression in microarray experiments,” Statistical Applications in Genetics and Molecular Biology, vol. 3, article 3, 2004. View at Publisher · View at Google Scholar · View at MathSciNet
  19. 2015, http://cran.r-project.org/package=caret.
  20. A. Karatzoglou, “Kernlab—an S4 package for Kernel methods in R,” Journal of Statistical Software, vol. 11, no. 9, pp. 1–20, 2004. View at Google Scholar
  21. 2015, https://www.r-project.org/.
  22. C. A. Hoeffer, A. Dey, N. Sachan et al., “The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling,” The of Neuroscience, vol. 27, no. 48, pp. 13161–13172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Y. Lee, H. J. Lee, E. J. Lee et al., “Down syndrome candidate region-1 protein interacts with Tollip and positively modulates interleukin-1 receptor-mediated signaling,” Biochimica et Biophysica Acta—General Subjects, vol. 1790, no. 12, pp. 1673–1680, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Tsilingaridis, T. Yucel-Lindberg, and T. Modéer, “T-helper-related cytokines in gingival crevicular fluid from adolescents with Down syndrome,” Clinical Oral Investigations, vol. 16, no. 1, pp. 267–273, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Hibaoui, I. Grad, A. Letourneau et al., “Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21,” EMBO Molecular Medicine, vol. 6, no. 2, pp. 259–277, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. R. J. Siarey, A. Kline-Burgess, M. Cho et al., “Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of Down syndrome,” Journal of Neurochemistry, vol. 98, no. 4, pp. 1266–1277, 2006. View at Publisher · View at Google Scholar
  27. J. H. Sitz, K. Baumgärtel, B. Hämmerle et al., “The down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4,” Neuroscience, vol. 157, no. 3, pp. 596–605, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Guimerá, C. Casas, C. Pucharcòs et al., “A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region,” Human Molecular Genetics, vol. 5, no. 9, pp. 1305–1310, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Kolialexi, G. T. Tsangaris, N. Papantoniou et al., “Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma,” Prenatal Diagnosis, vol. 28, no. 8, pp. 691–698, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Chen, R. Chrast, C. Rossier, M. A. Morris, M. D. Lalioti, and S. E. Antonarakis, “Cloning of 559 potential exons of genes of human chromosome 21 by exon trapping,” Genome Research, vol. 6, no. 8, pp. 747–760, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Obeid, K. Hartmuth, W. Herrmann et al., “Blood biomarkers of methylation in Down syndrome and metabolic simulations using a mathematical model,” Molecular Nutrition and Food Research, vol. 56, no. 10, pp. 1582–1589, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. B. C. Yoo, N. Cairns, M. Fountoulakis, and G. Lubec, “Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (Beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease,” Dementia and Geriatric Cognitive Disorders, vol. 12, no. 3, pp. 219–225, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. H. E. Lockstone, L. W. Harris, J. E. Swatton, M. T. Wayland, A. J. Holland, and S. Bahn, “Gene expression profiling in the adult Down syndrome brain,” Genomics, vol. 90, no. 6, pp. 647–660, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Sun, M. Dierssen, N. Toran, D. D. Pollak, W.-Q. Chen, and G. Lubec, “A gel-based proteomic method reveals several protein pathway abnormalities in fetal Down syndrome brain,” Journal of Proteomics, vol. 74, no. 4, pp. 547–557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Khocht, K. Heaney, M. Janal, and B. Turner, “Association of interleukin-1 polymorphisms with periodontitis in Down syndrome,” Journal of oral science, vol. 53, no. 2, pp. 193–202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. R. W. Old, F. Crea, W. Puszyk, and M. A. Hultén, “Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome,” Reproductive BioMedicine Online, vol. 15, no. 2, article no. 2826, pp. 227–235, 2007. View at Publisher · View at Google Scholar · View at Scopus